Procter & Gamble earnings beat estimates, but quarterly sales disappoint

Procter & Gamble earnings beat estimates, but quarterly sales disappoint


P&G CEO Jon Moeller on Q4 results: Heading into next year in very good fundamental shape

Procter & Gamble on Tuesday reported mixed quarterly results, but the company’s volume increased for the first time in more than two years.

Volume excludes pricing, making the metric a more accurate reflection of demand than sales. Over the last several years, P&G’s price hikes across its portfolio, from diapers to detergent, fueled its sales growth, but volume flattened or even declined as consumers bought less of its products.

Shares of the company fell 4.6% in premarket trading.

Here’s what the company reported compared with what Wall Street was expecting, based on a survey of analysts by LSEG:

  • Earnings per share: $1.40 adjusted vs. $1.37 expected
  • Revenue: $20.53 billion vs. $20.74 billion expected

P&G reported fiscal fourth-quarter net income attributable to the company of $3.14 billion, or $1.27 per share, down from $3.38 billion, or $1.37 per share, a year earlier.

Excluding items, the company earned $1.40 per share.

Net sales of $20.53 billion were essentially flat compared with the year-ago period. P&G’s organic revenue, which excludes foreign currency, acquisitions and divestitures, increased 2% in the quarter.

P&G’s volume rose 1%, thanks to stronger demand for its grooming, health care, and fabric and home-care products. All three of those segments reported 2% volume growth for the quarter.

But the company’s beauty and baby, feminine and family care divisions continued to struggle. Both units saw volume fall 1%, hurt by lower demand for its pricey SK-II skin-care brand and diapers, respectively.

For fiscal 2025, P&G anticipates core net earnings per share in a range of $6.91 to $7.05. The company reiterated its revenue outlook of 2% to 4% growth.

Don’t miss these insights from CNBC PRO



Source

The White House is launching direct-to-consumer drug site Trump Rx. Here’s what to know
Business

The White House is launching direct-to-consumer drug site Trump Rx. Here’s what to know

U.S. President Donald Trump makes an announcement from the Oval Office at the White House in Washington, D.C., U.S. Nov. 6, 2025. Jonathan Ernst | Reuters President Donald Trump on Thursday is slated to announce the launch of TrumpRx – a direct-to-consumer website that is key to his administration’s efforts to lower prescription drug costs […]

Read More
Estée Lauder expects 0 million tariff hit to full-year profitability; stock sinks more than 20%
Business

Estée Lauder expects $100 million tariff hit to full-year profitability; stock sinks more than 20%

In this photo illustration the Estee Lauder Companies Inc. logo seen displayed on a smartphone with Estee Lauder Companies Inc. logo in the background.  Thiago Prudencio | Lightrocket | Getty Images Estée Lauder said Thursday it’s expecting a $100 million hit to its full-year profitability because of tariff impacts. The beauty company’s stock tumbled more […]

Read More
Cheaper tequila and canned cocktails were the only bright spots for booze during a rough 2025
Business

Cheaper tequila and canned cocktails were the only bright spots for booze during a rough 2025

Various cans of alcoholic ready-to-drink beverages including Captain Morgan Rum and Coke, Bacardi MoJito, Archers and Lemonade, Malibu and Pineapple, Pina Colada Cocktail and Gordon’s Gin and Tonic are displayed for sale in a supermarket on January 10, 2024. John Keeble | Getty Images The U.S. alcohol industry had another sobering year in 2025. Spirits […]

Read More